134 related articles for article (PubMed ID: 12409992)
1. A potential antidepressant activity of SA4503, a selective sigma 1 receptor agonist.
Skuza G; Rogóz Z
Behav Pharmacol; 2002 Nov; 13(7):537-43. PubMed ID: 12409992
[TBL] [Abstract][Full Text] [Related]
2. Anxiolytic- and antidepressant-like effects of 7-OH-DPAT, preferential dopamine D3 receptor agonist, in rats.
Rogóz Z; Skuza G; Kłlodzińska A
Pol J Pharmacol; 2004; 56(5):519-26. PubMed ID: 15591639
[TBL] [Abstract][Full Text] [Related]
3. Antidepressant-like effect of combined treatment with selective sigma receptor agonists and a 5-HT1A receptor agonist in the forced swimming test in rats.
Skuza G; Rogóz Z
Pharmacol Rep; 2007; 59(6):773-7. PubMed ID: 18195469
[TBL] [Abstract][Full Text] [Related]
4. Effect of antidepressant drugs administered repeatedly on the dopamine D3 receptors in the rat brain.
Maj J; Dziedzicka-Wasylewska M; Rogoz R; Rogóz Z
Eur J Pharmacol; 1998 Jun; 351(1):31-7. PubMed ID: 9698202
[TBL] [Abstract][Full Text] [Related]
5. The synergistic effect of selective sigma receptor agonists and uncompetitive NMDA receptor antagonists in the forced swim test in rats.
Skuza G; Rogóz Z
J Physiol Pharmacol; 2006 Jun; 57(2):217-29. PubMed ID: 16845227
[TBL] [Abstract][Full Text] [Related]
6. Antidepressant-like properties of the anti-Parkinson agent, piribedil, in rodents: mediation by dopamine D2 receptors.
Brocco M; Dekeyne A; Papp M; Millan MJ
Behav Pharmacol; 2006 Nov; 17(7):559-72. PubMed ID: 17021388
[TBL] [Abstract][Full Text] [Related]
7. Mechanism of synergistic action following co-treatment with pramipexole and fluoxetine or sertraline in the forced swimming test in rats.
Rogóz Z; Skuza G
Pharmacol Rep; 2006; 58(4):493-500. PubMed ID: 16963794
[TBL] [Abstract][Full Text] [Related]
8. Some behavioral effects of 1,3-di-o-tolylguanidine, opipramol and sertraline, the sigma site ligands.
Maj J; Rogóz Z; Skuza G
Pol J Pharmacol; 1996; 48(4):379-95. PubMed ID: 9112678
[TBL] [Abstract][Full Text] [Related]
9. Antidepressant effects of pramipexole, a novel dopamine receptor agonist.
Maj J; Rogóz Z; Skuza G; Kołodziejczyk K
J Neural Transm (Vienna); 1997; 104(4-5):525-33. PubMed ID: 9295183
[TBL] [Abstract][Full Text] [Related]
10. Repeated imipramine treatment enhances the 7-OH-DPAT-induced hyperactivity in rats: the role of dopamine D2 and D3 receptors.
Rogóz Z; Skuza G
Pol J Pharmacol; 2001; 53(6):571-6. PubMed ID: 11985330
[TBL] [Abstract][Full Text] [Related]
11. Nafadotride administration increases D1 and D1/D2 dopamine receptor mediated behaviors.
Dall'Olio R; Gaggi R; Voltattorni M; Tanda O; Gandolfi O
Behav Pharmacol; 2002 Dec; 13(8):633-8. PubMed ID: 12478213
[TBL] [Abstract][Full Text] [Related]
12. Antidepressant drugs attenuate 7-OH-DPAT-induced hypoactivity in rats.
Rogóz Z; Dziedzicka-Wasylewska M
Pol J Pharmacol; 2000; 52(5):331-6. PubMed ID: 11334224
[TBL] [Abstract][Full Text] [Related]
13. Behavioural effects in the rat of the putative dopamine D3 receptor agonist 7-OH-DPAT: comparison with quinpirole and apomorphine.
Depoortere R; Perrault G; Sanger DJ
Psychopharmacology (Berl); 1996 Apr; 124(3):231-40. PubMed ID: 8740044
[TBL] [Abstract][Full Text] [Related]
14. Antidepressant-like effect of D(2/3) receptor-, but not D(4) receptor-activation in the rat forced swim test.
Basso AM; Gallagher KB; Bratcher NA; Brioni JD; Moreland RB; Hsieh GC; Drescher K; Fox GB; Decker MW; Rueter LE
Neuropsychopharmacology; 2005 Jul; 30(7):1257-68. PubMed ID: 15688083
[TBL] [Abstract][Full Text] [Related]
15. Modulation of the locomotor responses induced by D1-like and D2-like dopamine receptor agonists and D-amphetamine by NMDA and non-NMDA glutamate receptor agonists and antagonists in the core of the rat nucleus accumbens.
David HN; Sissaoui K; Abraini JH
Neuropharmacology; 2004 Feb; 46(2):179-91. PubMed ID: 14680757
[TBL] [Abstract][Full Text] [Related]
16. The influence of repeated treatment with imipramine, (+)- and (-)-oxaprotiline on behavioural effects of dopamine D-1 and D-2 agonists.
Maj J; Papp M; Skuza G; Bigajska K; Zazula M
J Neural Transm; 1989; 76(1):29-38. PubMed ID: 2565359
[TBL] [Abstract][Full Text] [Related]
17. The selective sigma(1) receptor agonist, 1-(3,4-dimethoxyphenethyl)-4-(phenylpropyl)piperazine (SA4503), blocks the acquisition of the conditioned place preference response to (-)-nicotine in rats.
Horan B; Gardner EL; Dewey SL; Brodie JD; Ashby CR
Eur J Pharmacol; 2001 Aug; 426(1-2):R1-2. PubMed ID: 11525784
[TBL] [Abstract][Full Text] [Related]
18. The role of D1 and D2 receptors in the heightened locomotion induced by direct and indirect dopamine agonists in rats with hippocampal damage: an animal analogue of schizophrenia.
Mittleman G; LeDuc PA; Whishaw IQ
Behav Brain Res; 1993 Jun; 55(2):253-67. PubMed ID: 8102851
[TBL] [Abstract][Full Text] [Related]
19. On the mechanism of antidepressant-like action of berberine chloride.
Kulkarni SK; Dhir A
Eur J Pharmacol; 2008 Jul; 589(1-3):163-72. PubMed ID: 18585703
[TBL] [Abstract][Full Text] [Related]
20. Interactions between D1 and D2 dopamine receptor family agonists and antagonists: the effects of chronic exposure on behavior and receptor binding in rats and their clinical implications.
Braun AR; Laruelle M; Mouradian MM
J Neural Transm (Vienna); 1997; 104(4-5):341-62. PubMed ID: 9295170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
